KHP Capital’s Medtronic MDT Stock Holding History

KHP Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$98K	Hold	1,000	–	–	0.06%	91
2018 Q2	$86K	Hold	1,000	–	–	0.06%	89
2018 Q1	$80K	Buy	+1,000	New	+$82.5K	0.06%	88

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KHP Capital's MDT Position: Q3 2018 in Review

KHP Capital held its Medtronic (MDT) position steady in Q3 2018 at 1,000 shares worth $98K. The position accounts for 0.06% of the portfolio, ranked #91.

KHP Capital first reported a position in MDT in Q1 2018 and has held it in 3 quarters since. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

KHP Capital held 1,000 shares of Medtronic worth $98K as of Q3 2018.
KHP Capital left its Medtronic share count unchanged in Q3 2018.
Medtronic made up 0.06% of KHP Capital's portfolio in Q3 2018, its #91 holding.
KHP Capital first reported a position in Medtronic in Q1 2018 and has held it in 3 quarters since.
1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.